Press coverage about Novadaq Technologies (NASDAQ:NVDQ) (TSE:NDQ) has been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Novadaq Technologies earned a news sentiment score of 0.11 on Accern’s scale. Accern also assigned press coverage about the medical research company an impact score of 45.5987083499095 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Novadaq Technologies has a 1 year low of $5.84 and a 1 year high of $12.74. The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.30 and a current ratio of 3.49.

Several brokerages recently commented on NVDQ. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $11.75 price objective on shares of Novadaq Technologies in a report on Friday, September 1st. Canaccord Genuity reiterated a “hold” rating and issued a $11.75 target price on shares of Novadaq Technologies in a research report on Friday, September 1st. BidaskClub upgraded Novadaq Technologies from a “strong sell” rating to a “sell” rating in a research report on Tuesday, August 22nd. Northland Securities restated a “hold” rating and set a $11.75 price objective on shares of Novadaq Technologies in a research report on Monday, August 14th. Finally, Zacks Investment Research upgraded Novadaq Technologies from a “sell” rating to a “hold” rating in a research report on Friday, August 18th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $11.86.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://www.watchlistnews.com/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-novadaq-technologies-nvdq-stock-price/1756313.html.

Novadaq Technologies Company Profile

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Insider Buying and Selling by Quarter for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.